Quick answer: A LSD For Anxiety randomized, placebo-controlled Phase 2b trial published in JAMA found that a single oral dose of MM120, an investigational LSD formulation developed by MindMed, produced significant reductions in generalized anxiety disorder symptoms...
Quick answer: The FDA declined to approve MDMA-assisted therapy for PTSD, citing gaps in safety data, questions about how long the benefits last, and concerns about who was enrolled in the trials. The rejection letter is now public. It does not mean MDMA therapy is...
